RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma.
Journal of molecular cell biology
View this publicationJournal of molecular cell biology
View this publicationCells
View this publicationThe Journal of investigative dermatology
View this publicationThe Journal of infectious diseases
View this publicationThe Journal of experimental medicine
View this publicationCurrent opinion in immunology
View this publicationMolecular cell
View this publicationInternational journal of cancer
View this publicationPublication categories: Top publication
The Journal of experimental medicine
View this publicationJournal of virology
View this publication